Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Parkinson Disease 4, Autosomal Dominant Lewy Body × camrelizumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Hepatocellular 9 Stomach Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Uterine Cervical Neoplasms 2 Nasopharyngeal Carcinoma 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Cervical Cancer Metastatic 2 Carcinoma, Non-Small-Cell Lung 2 Adenocarcinoma 2 Triple Negative Breast Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1 Pancreatic Neoplasms 1 Non-squamous Non-small-cell Lung Cancer 1 Mouth Neoplasms 1 Lung Neoplasms 1 Locally Advanced Rectal Cancer 1 Leukemia, Myeloid, Acute 1 Laryngeal Neoplasms 1 Gestational Trophoblastic Disease 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Esophageal Squamour Cell Cancer 1 Endometrioid Endometrial Cancer 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Breast Neoplasms 1 Biliary Tract Neoplasms 1 Advanced Gastric Cancer 1

Interventions

pembrolizumab 104 Cisplatin 28 lenvatinib 26 Paclitaxel 24 Carboplatin 24 Pemetrexed 13 Gemcitabine 9 Docetaxel 9 Saline Solution 8 Fluorouracil 8 Capecitabine 7 olaparib 6 Oxaliplatin 6 Bevacizumab 6 Albumin-Bound Paclitaxel 6 epacadostat 5 Etoposide 5 Cetuximab 5 belzutifan 4 Leucovorin 4 130-nm albumin-bound paclitaxel 4 patritumab deruxtecan 3 enzalutamide 3 durvalumab 3 Glucose 3 Dexamethasone 3 Acetaminophen 3 trifluridine tipiracil drug combination 2 regorafenib 2 liposomal doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡